ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 042,95
-0,63%
Dow Jones
41 985,35
0,08%
DAX
22 891,68
-0,53%
Brent Oil
71,775
0,00%
Bitcoin
84 377,39
0,39%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. ReShape Lifesciences Inc (RSLS) Cours

ReShape Lifesciences Inc

ReShape Lifesciences Inc (RSLS)

NASDAQ
0,664
-0,032
(-4,60%)
Fermé 22 Mars 9:00PM
Retardé de 15 minutes
0,6899
0,0259
(3,90%)
Après les heures de négociation: 12:50AM
Retardé de 15 minutes

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Statistiques et détails clés

Dernier
0,6899
Prix Achat
0,665
Prix Vente
0,69
Volume échangé
123 544
0,636 Fourchette du Jour 0,695
0,5964 Plage de 52 semaines 29,00
Cap du marché
491,678k
Clôture Veille
0,696
Ouverture
0,664
Dernière Transaction
83
@
0.6668
Dernière heure de transaction
Volume financier
US$ 80 980
VWAP
0,655474
Volume moyen (3 m)
1 227 401
Actions en circulation
712 680
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-0,04
Bénéfice par action (BPA)
-15,98
Chiffre d'affairess
8,68M
Bénéfice net
-11,39M

À propos de ReShape Lifesciences Inc

Reshape Lifesciences Inc is a developer of minimally invasive medical devices to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, the ReShape Vest, an investigational device, to help treat more patients with obesity, a... Reshape Lifesciences Inc is a developer of minimally invasive medical devices to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, the ReShape Vest, an investigational device, to help treat more patients with obesity, and ReShapeCare, a virtual coaching program delivered through an app. Show more

Secteur
Surgical,med Instr,apparatus
Industrie
Surgical,med Instr,apparatus
Site Web
www.reshapelifesciences.com
Siège social
Wilmington, Delaware, USA
Fondé
-
ReShape Lifesciences Inc est coté dans le secteur Surgical,med Instr,apparatus de la NASDAQ avec le ticker RSLS. Le dernier cours de clôture d'ReShape Lifesciences était de US$0,70. Au cours de la dernière année, les actions de ReShape Lifesciences ont été négociées dans une fourchette de prix de US$ 0,5964 à US$ 29,00.

ReShape Lifesciences compte actuellement 712 680 actions en circulation. La capitalisation boursière d'ReShape Lifesciences est de US$496 025,28 . ReShape Lifesciences a un ratio cours/bénéfice (ratio PE) de -0.04.

RSLS Dernières nouvelles

Plus de nouvelles

Form 8-K - Current report
Edgar (US Regulatory)
20 Mars 2025
RSLS (-4,60%)

Form DEF 14A - Other definitive proxy statements
Edgar (US Regulatory)
14 Mars 2025
RSLS (-4,60%)

Form PRER14A - Preliminary Proxy Soliciting materials
Edgar (US Regulatory)
13 Mars 2025
RSLS (-4,60%)

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Edgar (US Regulatory)
24 Février 2025
RSLS (-4,60%)

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Edgar (US Regulatory)
24 Février 2025
RSLS (-4,60%)

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Edgar (US Regulatory)
21 Février 2025
RSLS (-4,60%)

Form 8-K - Current report
Edgar (US Regulatory)
20 Février 2025
RSLS (-4,60%)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Edgar (US Regulatory)
18 Février 2025
RSLS (-4,60%)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.04997.7968750.640.74990.59641927260.65509638CS
4-0.5101-42.50833333331.21.410.59649275641.07363125CS
12-4.0601-85.47578947374.755.190.596412274011.29393633CS
26-5.2101-88.3067796615.912.12990.59646691782.3020089CS
52-9.3383-93.120400470710.0282290.5964203969212.16216706CS
156-3131.3101-99.9779725415313244660.59641593361114.81880494CS
260-752.4401-99.9083956289753.13275500.596414163813025.78543781CS

RSLS - Frequently Asked Questions (FAQ)

What is the current ReShape Lifesciences share price?
The current share price of ReShape Lifesciences is US$ 0,6899
How many ReShape Lifesciences shares are in issue?
ReShape Lifesciences has 712 680 shares in issue
What is the market cap of ReShape Lifesciences?
The market capitalisation of ReShape Lifesciences is USD 496,03k
What is the 1 year trading range for ReShape Lifesciences share price?
ReShape Lifesciences has traded in the range of US$ 0,5964 to US$ 29,00 during the past year
What is the PE ratio of ReShape Lifesciences?
The price to earnings ratio of ReShape Lifesciences is -0,04
What is the cash to sales ratio of ReShape Lifesciences?
The cash to sales ratio of ReShape Lifesciences is 0,05
What is the reporting currency for ReShape Lifesciences?
ReShape Lifesciences reports financial results in USD
What is the latest annual turnover for ReShape Lifesciences?
The latest annual turnover of ReShape Lifesciences is USD 8,68M
What is the latest annual profit for ReShape Lifesciences?
The latest annual profit of ReShape Lifesciences is USD -11,39M
What is the registered address of ReShape Lifesciences?
The registered address for ReShape Lifesciences is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the ReShape Lifesciences website address?
The website address for ReShape Lifesciences is www.reshapelifesciences.com
Which industry sector does ReShape Lifesciences operate in?
ReShape Lifesciences operates in the SURGICAL,MED INSTR,APPARATUS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
SGLYSingularity Future Technology Ltd
US$ 1,6799
(143,43%)
30,76M
WINVWinVest Acquisition Corporation
US$ 25,00
(107,30%)
463
VVPRVivoPower International PLC
US$ 1,2899
(52,13%)
65,08M
RNAZTransCode Therapeutics Inc
US$ 1,12
(45,45%)
216,22M
GLTOGalecto Inc
US$ 6,00
(44,93%)
10,71M
YHCLQR House Inc
US$ 0,40
(-82,38%)
38,32M
KZIAKazia Therapeutics Ltd
US$ 0,9759
(-80,02%)
55,66k
DMNDamon Inc
US$ 0,0373
(-70,02%)
304,17M
TCBPTC BioPharm Holdings PLC
US$ 0,5046
(-67,23%)
5,9M
SOWGSow Good Inc
US$ 1,53
(-44,36%)
698,02k
DMNDamon Inc
US$ 0,0373
(-70,02%)
301,97M
NVDANVIDIA Corporation
US$ 117,70
(-0,70%)
259,06M
RNAZTransCode Therapeutics Inc
US$ 1,12
(45,45%)
215,3M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 9,03
(10,66%)
174,28M
HOLOMicroCloud Hologram Inc
US$ 1,00
(32,36%)
141,86M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
RSLS
ReShape Lifesciences
Delayed Upgrade Clock
ADVFN Logo
France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces